健康大视野·医学分册2023,Issue(11) :47-48.DOI:10.3969/j.issn.1005-0019.2023.11.021

信迪利单抗治疗老年晚期胃癌患者临床疗效及安全性研究

吴姗姗 刘永坦
健康大视野·医学分册2023,Issue(11) :47-48.DOI:10.3969/j.issn.1005-0019.2023.11.021

信迪利单抗治疗老年晚期胃癌患者临床疗效及安全性研究

吴姗姗 1刘永坦2
扫码查看

作者信息

  • 1. 兖州区人民医院肿瘤科,山东 济宁 272000
  • 2. 兖州区人民医院影像科,山东 济宁 272000
  • 折叠

摘要

目的:探讨信迪利单抗联合奥沙利铂和替吉奥联合应用于老年晚期胃癌患者治疗中对临床疗效和安全性产生的影响.方法:将我院于2020年1月到2021年12月时间段内收治的60例老年晚期胃癌患者纳入本次研究对象的范畴,依据入院顺序随机数字分析法将其划分为参照组(n=30,治疗方式为奥沙利铂与替吉奥开展联合治疗)与研究组(n=30,治疗方式为信迪利单抗联合奥沙利铂和替吉奥开展治疗).比较和分析治疗前后两组患者的SF36生活质量评分、临床治疗总有效率和不良反应发生情况.结果:使用SF36评分量表对两组患者的心理健康、社

Abstract

Objective To investigate the effect of sindillizumab combined with oxaliplatin and Digio on clinical efficacy and safety in the treatment of elderly patients with advanced gastric cancer.Methods 60 elderly patients with advanced gastric cancer admitted to our hospital from January 2020 to December 2021 were included in the category of objects of this study.The patients were divided into a control group (n=30, oxaliplatin combined with Digio) and a study group (n=30, sindillizumab combined with oxaliplatin and Digio) according to sequential random number analysis on admission. The SF36 quality of life score, the total effective rate of clinical treatment and the occurrence of adverse reactions were compared and analyzed before and after treatment.Results The SF36 rating scale was used to compare the quality of life of the two groups in terms of mental health, social function, physical role and function.There was no significant difference between the two groups before treatment (P>0.05), and the scores of the two groups were significantly improved after treatment, and the study group was significantly higher than the reference group (P<0.05).The total effective rate of clinical treatment between the two groups was significantly higher in the study group than in the reference group (P<0.05), and the incidence of adverse reactions between the two groups was significantly lower in the study group than in the reference group (P<0.05), and the data between the two groups were statistically significant.Conclusion The application of Sindillimab combined with oxaliplatin and Teggio in the clinical treatment of elderly patients with advanced gastric cancer has a definite effect, which can significantly improve the quality of life of patients, significantly improve the clinical therapeutic effect, significantly reduce the incidence of adverse reactions, stable efficacy, safe and reliable, and has a high clinical application value.

关键词

替吉奥/信迪利单抗/晚期胃癌/疗效和安全性/应用价值

Key words

Tigio/Sindillimab/Advanced gastric cancer/Efficacy and safety/Application value

引用本文复制引用

出版年

2023
健康大视野·医学分册
中国保健协会

健康大视野·医学分册

ISSN:1005-0019
参考文献量7
段落导航相关论文